Mielodiszplasztikus szindróma (MDS): vizsgálatok itt: Ausztria
4 trials · From ClinicalTrials.gov, checked 2026. november 17.. Ask the study team whether a trial fits you.
- 3. fázisTaking peoplePhase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2
- Where
- Innsbruck, Linz, Rankweil, Salzburg, Vienna
- Életkor
- 18 év to 75 év
- People
- 650 worldwide
- Run by
- University of Ulm
See details and how to joinNCT04628026 · EU 2023-507518-28-00 - No phaseNot yet taking people in AusztriaCHIP in Health and Disease
- Where
- Innsbruck
- Életkor
- 18 év and over
- People
- 120
- Run by
- VASCage GmbH
See details and how to joinNCT07780552 - 2. fázisFut, nem toboroz(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00 - 2. fázisTaking peopleA Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 332 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04093570 · EU 2024-516293-29-01